PER
Click for more information
2.35% 8.7¢ percheron therapeutics limited

Based on the positive outcomes from the protein analysis...

  1. Baremoney
    236 Posts.
    lightbulb Created with Sketch. 59
    clock Created with Sketch.
    24/09/21
    09:39
    Post #: 56315660
    Based on the positive outcomes from the protein analysis reported above, Australian Provisional Patent Application No. 2021903024 was filed 20 September 2021 with claims covering applications of ATL1102in new potential disease settings including diabetic, respiratory and age-related diseases to support the Company’s future commercial and partnering plans for ATL1102.

    Asthma and dementia among others im guessing wow!
    ANP Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 17  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.002(2.35%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.